GROWTH OF HUMAN PANCREATIC-CANCER CELLS, INDUCED BY HUMAN PANCREATIC PHOSPHOLIPASE A(2), IS MEDIATED VIA ITS SPECIFIC RECEPTOR BUT NOT VIA ITS CATALYTIC PROPERTY

Citation
E. Kinoshita et al., GROWTH OF HUMAN PANCREATIC-CANCER CELLS, INDUCED BY HUMAN PANCREATIC PHOSPHOLIPASE A(2), IS MEDIATED VIA ITS SPECIFIC RECEPTOR BUT NOT VIA ITS CATALYTIC PROPERTY, International journal of oncology, 9(6), 1996, pp. 1219-1225
Citations number
37
Categorie Soggetti
Oncology
ISSN journal
10196439
Volume
9
Issue
6
Year of publication
1996
Pages
1219 - 1225
Database
ISI
SICI code
1019-6439(1996)9:6<1219:GOHPCI>2.0.ZU;2-#
Abstract
Human pancreatic phospholipase A(2) type I (hPLA(2)-I) has been found to stimulate the growth of human pancreatic cancer cell line, MIAPaCa- 2, which has a receptor for PLA(2). In the present study, half-maximal inhibitory concentrations (IC(50)s) for the mature- and pro-form of h PLA(2)-I and certain eukaryotic and prokaryotic PLA(2)s were determine d using ligand binding studies. The IC50 for the mature form was 3.5x1 0(-9) M compared to those for the pro-form and non-human PLA(2)s (over 5.0x10(-7) M), suggesting receptor specificity for mature hPLA(2)-I. Receptor binding was independent of Ca2+, which is required for PLA(2) 's digestive activity. Lysophospholipids, generated by PLA(2), showed no proliferative effect on the MIAPaCa-2 cells. Furthermore, MIAPaCa-2 cells treated with hPLA(2)-I did not release fatty acids. This implie s that proliferation of these cells is mediated by binding of hPLA(2)- I to the specific receptor, not by its enzymatic activity. The hPLA(2) -I induced cell proliferation was blocked by preincubation of the enzy me with anti-hPLA(2)-I monoclonal antibody.